Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease

European Journal of Endocrinology

Volumn 156, Issue 2, 2007, Pages 233-239

  Giraldi, Francesca Pecori ^a   Andrioli, Massimiliano ^a   De Marinis, Laura ^b   Bianchi, Antonio ^b   Giampietro, Antonella ^b   De Martin, Martina ^a   Sacco, Eugenia ^b   Scacchi, Massimo ^a   Pontecorvi, Alfredo ^b   Cavagnini, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTISONE ACETATE; HYDROCORTISONE; SERMORELIN; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACTH SECRETING ADENOMA; ADRENALECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DIAGNOSTIC TEST; DISEASE DURATION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERCORTISOLISM; LONG TERM CARE; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELAPSE; REMISSION; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRANSSPHENOIDAL SURGERY; BLOOD; CUSHING SYNDROME; FOLLOW UP; HYPOPHYSIS TUMOR; HYPOPITUITARISM; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; SEX RATIO;

ACTH-SECRETING PITUITARY ADENOMA; ADULT; AGED; ARGININE; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; RISK FACTORS; SEX DISTRIBUTION;

EID: 33947722381     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02329     Document Type: Article

References (44)

1. Styne DM, Grumbach MM, Kaplan SL, Wilson CB & Conte FA. Treatment of Cushing's disease in childhood and adolescence by transsphenoidal microadenomectomy. New England Journal of Medicine 1984 310 889-893.
2. Krieger DT & Glick SM. Sleep EEG stages and plasma growth hormone concentrations in states of endogenous and exogenous hypercortisolemia or ACTH elevation. Journal of Clinical Endocrinology and Metabolism 1974 399 86-1000,
3. Smals AE, Pieters GF, Smals AGH, Benraad TJ & Kloppenhorg PWC. Human pancreatic growth hormone-releasing hormone fails to stimulate human growth hormone both in Cushing's disease and Cushing's syndrome due to adrenocortical adenoma. Clinical Endocrinology 1986 24 401-407.
4. Veldman RG, Frölich M, Pincus SM, Veldhuis JD & Roelfsema F. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone and prolactin secretory dynamics in adults with Cushing's disease after clinically successfull transsphenoidal adenomectomy. Journal of Clinical Endocrinology and Metabolism 2000 85 4039-4046.
5. Tzanela M, Karavitaki N, Stylianidou C, Tsagarakis S & Thalassinos N. Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clinical Endocrinology 2004 60 309-314.
6. Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB & Savage MO. Final adult height and body mass index after cure of paediatric Cushing's disease. Clinical Endocrinology 2005 62 466-472.
7. Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM & Savage MO. Linear growth and final height after treatment for Cushing's disease in childhood. Journal of Clinical Endocrinology and Metabolism 2000 85 3262-3265.
8. Degerblad M, Brismar K, Rahn T & Thorén M. The hypothalamus-pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency. Journal of Internal Medicine 2003 253 454-462.
9. Corneli G, Di Somma C, Balzelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F & Aimaretti G. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. European Journal of Endocrinology 2005 153 257-264.
10. Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F & the Study Group of the Italian Society of Endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Journal of Clinical Endocrinology and Metabolism 1999 84 440-448.
11. Pecori Giraldi E Scaroni C, Arvat E, Do Martin M, Giordano R, Albiger N, Leao AAS, Picu A, Mantero F & Cavagnini F. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease. Clinical Endocrinology 2006 64 219-224.
12. Wallander M, Brismar K, Ohrvik J, Ryden L & Norhammar A. Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia 2006 49 2247-2255.
13. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F & Ghigo E. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. Journal of Clinical Endocrinology and Metabolism 1998 83 1615-1618.
14. Biller BMK, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg D, Chipman JJ & Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 2002 87 2067-2079.
15. Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F & Savage MO. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion. Clinical Endocrinology 2004 60 169-174.
16. Storr HL, Afshar F, Matson M, Sabin L Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB & Savage MO. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. European Journal of Endocrinology 2005 152 825-833.
17. Johannsson G, Sunnerhagen KS & Svensson J. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease. Clinical Endocrinology 2004 60 550-559.
18. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Barnmert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, Wuster C & the KIMS international Study Board on behalf of the KIMS Study Group. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. European Journal of Endocrinology 2002 146 67-74.
19. Hughes NR, Lissett CA & Shalet SM. Growth hormone status following treatment for Cushing's syndrome. Clinical Endocrinology 1999 51 61-66.
20. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW Hoftijzer HC, Smit AJ, Roelfsema F, Lamberts SWJ & Romijn J. Quality of life in patients after long-term biochemical cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2005 90 3279-3286.
21. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G & Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. {i Quarterly Journal of Medicine 1989 70 145-160.
22. Magiakou MA, Mastorakos G, Gomez MT, Rose SR & Chrousos GP. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. Journal of Clinical Endocrinology and Metabolism 1994 78 131-137.
23. Kuwayama A, Kageyama N, Nakane T, Watanabe M & Kanie N. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1981 53 65-173.
24. Nakane T, Kuwayama A, Watanabe M, Takahashi T, Kato T, Ichihara K & Kageyama N. Long-term results of transsphenoidal adenomectomy in patients with Cushing's disease. Neurosurgery 1987 21 218-222.
25. Mukherjee A, Murray RD, Teasdale GM & Shalet SM. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Clinical Endocrinology 2004 60 476-483.
26. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
27. Giustina A, Bossoni S, Bodini C, Girelli A, Balestrieri GP, Pizzocolo G & Wehrenberg WB. Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy. Journal of Clinical Endocrinology and Metabolism 1992 743 1301-1305.
28. Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, Ghigo MC & Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. Journal of Clinical Endocrinology and Metabolism 1990 71 1481-1485.
29. Magiakou MA, Mastorakos G, Zachman K & Chrousos GP. Blood pressure in children and adolescents with Cushing's syndrome before and after surgical cure. Journal of Clinical Endocrinology and Metabolism 1997 82 1734-1738.
30. Mancini T, Kola B, Mantero F, Boscaro M & Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clinical Endocrinology 2004 61 768-777.
31. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M & Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after live years of successful cure. Journal of Clinical Endocrinology and Metabolism 1999 84 2664-2672.
32. Qu XD, Gonzalo ITG, Al Sayed MY, Cohan F, Christenson PD, Swerdloff RS, Kelly DF & Wang C. Influence of body mass index and gender on growth hormone (GH) response to GH-releasing hormone plus arginine and insulin tolerance tests. Journal of Clinical Endocrinology and Metabolism 2005 90 1563-1569.
33. Carmichael JD, Danoff A, Milani D, Roubenoff R, Lesser ML, Livote E, Reitz RE, Ferris S & Kleinberg D. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clinical Endocrinology 2006 65 169-177.
34. Pecori Giraldi F, Moro M, Cavagnini F & the Study Group of the Italian Society of Endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. Gender-related differences in the presentation and course of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2003 88 1554-1558.
35. Borges MH, DiNinno FB & Lengyel AMJ. Different effects of growth hormone-releasing peptide (GHRP-6) and GH-releasing homone on GH release in endogenous and exogenous hypercortisolism. Clinical Endocrinology 1997 46 713-718.
36. Senaris RM, Lago F, Coya R, Pineda J & Dieguez C. Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids. Endocrinology 1996 137 5236-5241.
37. Wehrenberg WB, Bergman PJ, Stagg L, Ndon J & Giustina A. Glucocorticoid inhibition of growth hormone in rats: partial reversal with somatostatin antibodies. Endocrinology 1990 127 2705-2708.
38. Leal Cerro A, Soto A, Martinez MA, Alvarez P, Isidro L, Casanueva FF, Dieguez C & Cordido F. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome. Clinical Endocrinology 2002 57 745-749.
39. Procopio M, Invitti C, Maccario M, Grottoli S, Cavagnini F, Camanni F & Ghigo E. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. International Journal of Obesity and Related Metabolic Disorders 1995 19 108-112.
40. Webb SM, Rigla M, Wägner A, Oliver B & Bartumeus F. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 1999 84 3696-3700.
41. Corneli G, Baldelli R, Di Somma C, Rovere S, Gaia D, Pellegrino M, Gasco V Durante C, Grottoli S, Colao A, Tamburrano G, Lombardi G, Ghigo E & Aimaretti G. Occurrence ofGH deficiency in adult patients who underwent neurosurgery in the hypothalamus-pituitary area for non-functioning tumour masses. Growth Hormone and IGF Research 2003 13 104-108.
42. Hoeck HC, Bang F & Laurberg P Impaired growth hormone secretion in patients operated for pituitary adenomas. Growth Regulation 1994 4 63-67.
43. Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G & Colao A. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. Clinical Endocrinology 2003 58 302-308.
44. Colao A, Di Somma C, Spiezia S, Rota F, Pivonello R, Savastano S & Lombardi G. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. Journal of Clinical Endocrinology and Metabolism 2006 91 2191-2300.